Today’s guest post comes from Chip Parkinson, CEO at Gifthealth.
Chip discusses how Direct-to-Patient (DTP) models can transform the manufacturer access model for prescription therapies. He argues that a tech-plus-touch, end-to-end approach can improve patient access, protect manufacturer economics, and increase brand trust and loyalty.
Read on for Chip’s insights.
